These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency. Asselta R, Platè M, Robusto M, Borhany M, Guella I, Soldà G, Afrasiabi A, Menegatti M, Shamsi T, Peyvandi F, Duga S. Thromb Haemost; 2015 Mar; 113(3):567-76. PubMed ID: 25427968 [Abstract] [Full Text] [Related]
5. Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion. Vu D, de Moerloose P, Batorova A, Lazur J, Palumbo L, Neerman-Arbez M. J Med Genet; 2005 Sep; 42(9):e57. PubMed ID: 16141000 [Abstract] [Full Text] [Related]
6. A novel frameshift mutation in FGA accounting for congenital afibrinogenemia predicted to encode an aberrant peptide terminating 158 amino acids downstream. Robert-Ebadi H, de Moerloose P, El Khorassani M, El Khattab M, Neerman-Arbez M. Blood Coagul Fibrinolysis; 2009 Jul; 20(5):385-7. PubMed ID: 19417632 [Abstract] [Full Text] [Related]
7. Pseudo-exon activation caused by a deep-intronic mutation in the fibrinogen gamma-chain gene as a novel mechanism for congenital afibrinogenaemia. Spena S, Asselta R, Platé M, Castaman G, Duga S, Tenchini ML. Br J Haematol; 2007 Oct; 139(1):128-32. PubMed ID: 17854317 [Abstract] [Full Text] [Related]
8. A novel nonsense mutation in the FGA gene in a Chinese family with congenital afibrinogenaemia. Wu S, Wang Z, Dong N, Bai X, Ruan C. Blood Coagul Fibrinolysis; 2005 Apr; 16(3):221-6. PubMed ID: 15795544 [Abstract] [Full Text] [Related]
9. A novel frameshift mutation in FGA (c.1846 del A) leading to congenital afibrinogenemia in a consanguineous Syrian family. Levrat E, Aboukhamis I, de Moerloose P, Farho J, Chamaa S, Reber G, Fort A, Neerman-Arbez M. Blood Coagul Fibrinolysis; 2011 Mar; 22(2):148-50. PubMed ID: 21245743 [Abstract] [Full Text] [Related]
15. Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia. Vu D, Di Sanza C, Caille D, de Moerloose P, Scheib H, Meda P, Neerman-Arbez M. Hum Mol Genet; 2005 Nov 01; 14(21):3271-80. PubMed ID: 16195396 [Abstract] [Full Text] [Related]
17. The molecular basis of inherited afibrinogenaemia. Neerman-Arbez M. Thromb Haemost; 2001 Jul 01; 86(1):154-63. PubMed ID: 11487003 [Abstract] [Full Text] [Related]
18. FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations. Casini A, Lukowski S, Quintard VL, Crutu A, Zak M, Regazzoni S, de Moerloose P, Neerman-Arbez M. Thromb Res; 2014 May 01; 133(5):868-74. PubMed ID: 24560896 [Abstract] [Full Text] [Related]
19. Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'. Vorjohann S, Fish RJ, Biron-Andréani C, Nagaswami C, Weisel JW, Boulot P, Reyftmann L, de Moerloose P, Neerman-Arbez M. Thromb Haemost; 2010 Nov 01; 104(5):990-7. PubMed ID: 20806111 [Abstract] [Full Text] [Related]